Axel Mark News

Axel Mark: Ascella Biosystems Inc. wins research grant to develop infectious disease diagnostic technology

Nov 20 15:00

Axel Mark: change report

Nov 20 13:15

Axel Mark: Correction Report (Mass Ownership Report/Change Report)

Nov 19 12:47

Axel Mark: Mass Ownership Report

Nov 15 09:25

Axel Mark: Full year financial results briefing materials for the fiscal year ending September 2024

Nov 14 14:30

Axel Mark: Notice regarding job offers for executive personnel

Nov 14 14:30

Axel Mark: Notice regarding partial changes to the Articles of Incorporation

Nov 14 14:30

Axel Mark: Summary of financial results for the fiscal year ending September 2024 [Japanese GAAP] (unconsolidated)

Nov 14 14:30

Axel Mark: Mass Ownership Report

Nov 14 11:20

Axel Mark: Notice regarding completion of payment for the 29th Stock Acquisition Rights (with exercise price amendment clause) and 30th Stock Acquisition Rights through third party allotment

Nov 11 14:30

Axel Mark: Mass holding report (stock certificates subject to special cases, etc.)

Nov 8 13:07

Axel Mark: (Correction) Notice Concerning Issuance of Stock Acquisition Rights through Third-Party Allotment and Adjustments to the Conversion Value and Exercise Price of Stock Acquisition Rights for Unsecured Convertible Bonds with Stock Acquisition Rights

Oct 31 15:00

Axel Mark: Corrected securities registration form (built-in method)

Oct 31 14:20

Axel Mark: Notice Concerning Issuance of Stock Acquisition Rights through Third-Party Allotment and Adjustments to the Conversion Value and Exercise Price of Stock Acquisition Rights for Unsecured Convertible Bond-Type Stock Acquisition Rights Corporate Bonds

Oct 24 15:30

Axel Mark: Securities registration statement (embedding method)

Oct 24 15:08

Axel Mark: Interim report

Aug 8 14:06

Axel Mark: Third quarter financial report for the September 2024 period (Japanese standard) (non-consolidated)

Aug 8 14:00

Axel Mark: Announcements of individual stock for the establishment of a subsidiary.

Aug 8 14:00

Axel Mark: Announcements of individual stocks regarding the recognition of special losses and the revision of financial estimates.

Aug 8 14:00

Axel Mark: Earnings conference materials for the third quarter of the fiscal year ending September 2024.

Aug 8 14:00